Big Pharma On Steady Footing Heading Into Second Half

 
• By Jessica Merrill

Large cap pharmaceutical manufacturers reassured investors that revenues are poised to grow in 2024. Now they need to deliver.

Several big pharma raised financial guidance at midyear • Source: Shutterstock

More from Earnings

More from Business